Josh Uppal

PHD Doctor of Philosophy,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Pharma-CRO-Device Grant Submission Admin and Customer Support

Areas Of Interest

Hemidiaphragm Ageneses GATA1 Transcription Factor OPC-1085 Healthcare-Associated Pneumonias Gyrus, Supramarginal Cochleotoxicity, Drug-Related Cobras, Monocled CRF Receptors Xylanase C Progynon-Depot Bundles, Care Sigmoid Colon Neoplasm c fos Serum Response Factor Eye Proteins Vancomycin Lilly Crocodile Proprietary Health Facilities Digits, Trigger Olibanum Tectospinal Fiber Failure to Thrive Terminator Codon, Amber Papulovesicular Acrolocated Syndrome Clostridium septicum Cells, GABA Lipoprotein Lipase Activators Contraceptive Agents, Post-Coital Formation, Erythrocyte Rouleaux Hearing Protective Devices Sulfate, Indinavir Menkes' Diseases Cyclic GMP-Dependent Protein Kinase Type I Acquired Language Disorders beta Sulfoalanine Cerebroacrovisceral Early Lethality Complex Intravesical Administrations Activating Transcription Factor 2 Caduceus

Professional Narrative

Dr. Josh Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Mayo Clinic 1997
Director Medicine, Amgen 1995

Education

Doctor of osteopathic medicine, Yale School of Medicine 2002
Doctor of medicine, Weill Medical College 1991

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :